Industry Verticals »

All Categories

Insights »

About TMR »

Stool Secretory Immunoglobulin A [SIgA] Market

Stool Secretory Immunoglobulin A [SIgA] Market (Use: Testing [Allergic Disease, Infection, GI Inflammation, and Autoimmune Disease] and Research; and End User: Hospitals, Labs and Diagnostic Centers, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Research and Development Activities to Open Up New Avenues

The global stool secretory immunoglobulin A (SIgA) market is expected to be driven by consistent rise in the diagnosis of selective IgA deficiencies in suspected cases due to chronic infection. The notable surge in the overall awareness pertaining to recurrent infection is another critical driver of the stool secretory immunoglobulin A (SIgA) market. At present, researchers are increasingly focusing on assessing the targets of immunoglobulin (Ig) A in comparison with IgG responses due to which, the growth of the stool secretory immunoglobulin A (SIgA) market is expected to remain steady during the forecast period.

Advancements in technology have enabled researchers to offer insights pertaining to gastrointestinal micro biota composition and its link with the host. Advancements in stool secretory immunoglobulin A (SIgA) continue to highlight the interaction between the host and micro biome due to which, the global stool secretory immunoglobulin A (SIgA) market is expected to grow at a steady pace. A notable rise in the adoption of preventive care for a healthier lifestyle is a major factor that is likely to propel the market for stool secretory immunoglobulin A (SIgA) during the assessment period.

At the back of these factors, the global stool secretory immunoglobulin A (SIgA) market is on course to reach US$ 38 Mn by the end of 2030.

Critical Role in Mucosal Homeostasis to Accelerate Market Growth

Immunoglobulin A (IgA) is one of the key immunoglobulins and plays a critical role in the mucosal homeostasis in respiratory, genitourinary, and gastrointestinal tracts. Moreover, it also provides optimum protection against antigens due to which, the stool secretory immunoglobulin A (SIgA) market is staring at a bright future. Selective IgA deficiency is a common and prevalent immunodeficiency among humans due to which, additional research is being carried out in the global stool secretory immunoglobulin A (SIgA) market to address this issue. The increasing demand for stool secretory immunoglobulin A (SIgA) to treat recurrent sino-pulmonary infections is another major factor that would propel the market. Furthermore, as IgA plays a key role in the body as an anti-inflammatory due to which, autoimmune conditions and allergic diseases occur. In addition, reduction in stool secretory immunoglobulin A (SIgA) leads to a weaker mucosal barrier and enables allergens to enter the bloodstream– an area that has attracted considerable attention from researchers.

Rise in Adoption in Diagnostic Centers and Labs to Bolster Market Growth

Hospitals, diagnostic centers, and labs are the most prominent end users within the global stool secretory immunoglobulin A (SIgA) market and the trend is expected to continue during the forecast period. A noteworthy amount of stool secretory immunoglobulin A tests are carried out at standalone and hospital-based diagnostic laboratories in several regions of the world, particularly in developed regions, including North America and Europe. A number of top tier market players involved in the current stool secretory immunoglobulin A (SIgA) market landscape are largely based in North America due to which, the region is expected to remain at the forefront in terms of market growth and share.

Market Growth Likely to Remain Steady amid COVID-19 Pandemic

The advent of the COVID-19 pandemic is expected to have a moderate impact on the overall growth of the global stool secretory immunoglobulin A (SIgA) market in 2020. Research and development activities are likely to continue in full swing, as governments in all the nations have given the green light to research and development activities pertaining to the healthcare sector. Although the primary focus of governments in several nations is projected to remain on curbing the transmission of the novel COVID-19 infection, the growth of the stool secretory immunoglobulin A (SIgA) market is expected to remain steady amid the COVID-19 pandemic.

Analysts’ Viewpoint

The global stool secretory immunoglobulin A (SIgA) market is expected to expand at a moderate CAGR of ~3% during the forecast period. The market growth is primarily driven by advancements in technology, research and development activities, and significant rise in healthcare expenditure worldwide. Market players should focus on research and continue to eye collaboration opportunities with researchers to gain a competitive edge.

Stool Secretory Immunoglobulin A (SIgA) Market: Overview

  • According to Transparency Market Research’s latest report on the global stool secretory immunoglobulin A (SIgA) market for the historical period 2018–2019 and forecast period 2020–2030, the global stool secretory immunoglobulin A (SIgA) market is driven by the rise in the diagnosis of selective IgA deficiency in suspected cases due to chronic infection
  • According to the report, the global stool secretory immunoglobulin A (SIgA) market was valued at ~US$ 27 Mn in 2019. It is anticipated to expand at a CAGR of ~3% from 2020 to 2030.

Increase in Awareness Regarding Recurrent Infection: Key Driver of Stool Secretory Immunoglobulin A (SIgA) Market

  • Rise in the adoption of preventive care for healthy lifestyle, diagnosis of selective IgA deficiency in suspected cases due to of chronic or recurrent infections, autoimmune diseases, chronic diarrhea, and benefits offered by secretory immunoglobulin A (SIgA) diagnostics are expected to propel the market during the forecast period
  • Increase in recurrent respiratory tract infections, gastric infections, and rise in occurrence of autoimmune diseases in North America and Europe is projected to drive the secretory immunoglobulin A (SIgA) diagnostics market

Pricing Pressure: Key Restraint of Stool Secretory Immunoglobulin A (SIgA) Market

  • Product offering at relatively lower than average selling price has increased market penetration of local players having wide distribution network in certain geographies
  • This is imposing pricing pressure on major manufacturers, thereby intensifying competition. Dominance of local players offering a wide range of reagents portfolio at lower rates is hampering the geographic expansion of major players in particular regions. This is likely to act as a deterrent for manufacturers to expand their SigA test portfolio.

Mergers, Acquisitions, and Strategic Partnerships: Key Opportunities

  • Trend of mergers, acquisitions, and strategic partnerships in the life science industry has been observed over the past few years. These acquisitions and partnerships are primarily aimed at strengthening the company’s diagnostics test offering in various medical specialties, development of new products/tests, and to increase geographic presence.
  • For instance, in April 2017, ERBA Diagnostics Mannheim acquired Calbiotech Inc, a U.S.-based specialist in immunoassay development and manufacturing; Calbiotech Veterinary Diagnostics Inc, and Moduline Systems Inc

Stool Secretory Immunoglobulin A (SIgA) Market: Competition Landscape

  • This report profiles major players in the global stool secretory immunoglobulin A (SIgA) market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global stool secretory immunoglobulin A (SIgA) market is highly fragmented, owing to the presence of numerous international as well as regional players
  • Leading players operating in the global stool secretory immunoglobulin A (SIgA) market include
    • BioVendor Group
    • Sigma Diagnostics Inc.
    • American Laboratory Products Company
    • Calbiotech, Inc.
    • Eagle Biosciences
    • R-Biopharm AG
    • Tecan Trading AG

Stool Secretory Immunoglobulin A (SIgA) Market: Key Developments

  • Key players in the global stool secretory immunoglobulin A (SIgA) market are engaged in regulatory approvals, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to augment the global stool secretory immunoglobulin A (SIgA) market. A few expansion strategies adopted by players operating in the global stool secretory immunoglobulin A (SIgA) market are:
  • In April 2019, StressMarq signed a distribution agreement with Eagle Biosciences Inc. for the distribution of its products in the U.S.
  • The report on the global stool secretory immunoglobulin A (SIgA) market discusses individual strategies, followed by company profiles of manufacturers and suppliers of stool secretory immunoglobulin A (SIgA). The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global stool secretory immunoglobulin A (SIgA) market.

Frequently Asked Questions

What is the total market worth of stool secretory immunoglobulin A market?

Stool secretory immunoglobulin A market to reach valuation of US$ 38 Mn by 2030

What is the anticipated CAGR of the stool secretory immunoglobulin A market in the forecast period?

Stool secretory immunoglobulin A market is projected to expand at a CAGR of ~3% from 2020 to 2030

What are the key driving factors for the growth of the stool secretory immunoglobulin A market?

Stool secretory immunoglobulin A market is driven by rise in the diagnosis of selective IgA deficiencies in suspected cases due to chronic infection

Which region is expected to project the highest market share in the global stool secretory immunoglobulin A market?

North America dominated the global stool secretory immunoglobulin A market, the trend is anticipated to continue during the forecast period

Who are the key players in the global stool secretory immunoglobulin A market?

Key players in the global stool secretory immunoglobulin A market include BioVendor Group, Sigma Diagnostics Inc., American Laboratory Products Company, Calbiotech, Inc., Eagle Biosciences

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Stool Secretory Immunoglobulin A (SIgA) Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Overview

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunity

5. Key Insights

    5.1. Pricing Analysis – by Company

    5.2. Global Stool Secretory Immunoglobulin A (SIgA) Market – Regulatory Scenario

    5.3. Global Stool Secretory Immunoglobulin A (SIgA) Market ­- Key Industry Development

    5.4. COVID-19 Impact Analysis (demand for its Use in research, supply chain, etc.)

6. Global Stool Secretory Immunoglobulin A (SIgA) Market Analysis and Forecast, by Use

    6.1. Key Findings / Developments

    6.2. Introduction & Definition

    6.3. Global Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by Use, 2018–2030

        6.3.1. Testing

            6.3.1.1. Allergic Disease

            6.3.1.2. Infection

            6.3.1.3. GI Inflammation

            6.3.1.4. Autoimmune Disease

            6.3.1.5. Others

        6.3.2. Research

    6.4. Global Stool Secretory Immunoglobulin A (SIgA) Market Attractiveness Analysis, by Use

7. Global Stool Secretory Immunoglobulin A (SIgA) Market Analysis and Forecast, by End-user

    7.1. Key Findings / Developments

    7.2. Introduction & Definition

    7.3. Global Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by End-user, 2018–2030

        7.3.1. Hospitals

        7.3.2. Labs and Diagnostic Centers

        7.3.3. Others

    7.4. Global Stool Secretory Immunoglobulin A (SIgA) Market Attractiveness Analysis, by End-user

8. Global Stool Secretory Immunoglobulin A (SIgA) Market Analysis and Forecast, by Geography/Region

    8.1. Geographical Representation

    8.2. Global Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Global Stool Secretory Immunoglobulin A (SIgA) Market Attractiveness Analysis, by Region

9. North America Stool Secretory Immunoglobulin A (SIgA) Market Analysis and Forecast

    9.1. North America Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by Country, 2018–2030

        9.1.1. U.S.

        9.1.2. Canada

    9.2. North America Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by Use, 2018–2030

    9.3. North America Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by End-user, 2018–2030

    9.4. North America Horseradish Peroxidase Market Attractiveness Analysis, 2020–2030

        9.4.1. By Country

        9.4.2. By Use

        9.4.3. By End-user

10. Europe Stool Secretory Immunoglobulin A (SIgA) Market Analysis and Forecast

    10.1. Europe Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by Country/Sub-region, 2018–2030

        10.1.1. Germany

        10.1.2. France

        10.1.3. U.K.

        10.1.4. Spain

        10.1.5. Italy

        10.1.6. Rest of Europe

    10.2. Europe Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by Use, 2018–2030

    10.3. Europe Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by End-user, 2018–2030

    10.4. Europe Stool Secretory Immunoglobulin A (SIgA) Market Attractiveness Analysis, 2020–2030

        10.4.1. By Country/Sub-region

        10.4.2. By Use

        10.4.3. By End-user

11. Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Market Analysis and Forecast

    11.1. Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by Country/Sub-region, 2018–2030

        11.1.1. Japan

        11.1.2. China

        11.1.3. India

        11.1.4. Australia & New Zealand

        11.1.5. Rest of Asia Pacific

    11.2. Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by Use, 2018–2030

    11.3. Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by End-user, 2018–2030

    11.4. Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Market Attractiveness Analysis, 2020–2030

        11.4.1. By Country/Sub-region

        11.4.2. By Use

        11.4.3. By End-user

12. Latin America Stool Secretory Immunoglobulin A (SIgA) Market Analysis and Forecast

    12.1. Latin America Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by Country/Sub-region, 2018–2030

        12.1.1. Brazil

        12.1.2. Mexico

        12.1.3. Rest of Latin America

    12.2. Latin America Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by Use, 2018–2030

    12.3. Latin America Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by End-user, 2018–2030

    12.4. Latin America Stool Secretory Immunoglobulin A (SIgA) Market Attractiveness Analysis, 2020–2030

        12.4.1. By Country/Sub-region

        12.4.2. By Use

        12.4.3. By End-user

13. Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Market Analysis and Forecast

    13.1. Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by Country/Sub-region, 2018–2030

        13.1.1. GCC Countries

        13.1.2. South Africa

        13.1.3. Rest of Middle East & Africa

    13.2. Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by Use, 2018–2030

    13.3. Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Market Value Forecast, by End-user, 2018–2030

    13.4. Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Market Attractiveness Analysis, 2020–2030

        13.4.1. By Country/Sub-region

        13.4.2. By Use

        13.4.3. By End-user

14. Competitive Landscape

    14.1. Market Share Analysis, by Company, 2019

    14.2. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)

        14.2.1. Tecan Trading AG

            14.2.1.1. Company Details

            14.2.1.2. Company Description

            14.2.1.3. Business Overview

            14.2.1.4. SWOT Analysis

            14.2.1.5. Financial Analysis

            14.2.1.6. Strategic Overview

        14.2.2. R-Biopharm AG.

            14.2.2.1. Company Details

            14.2.2.2. Company Description

            14.2.2.3. Business Overview

            14.2.2.4. SWOT Analysis

            14.2.2.5. Strategic Overview

        14.2.3. Eagle Biosciences

            14.2.3.1. Company Details

            14.2.3.2. Company Description

            14.2.3.3. Business Overview

            14.2.3.4. SWOT Analysis

            14.2.3.5. Strategic Overview

        14.2.4. Calbiotech, Inc.

            14.2.4.1. Company Details

            14.2.4.2. Company Description

            14.2.4.3. Business Overview

            14.2.4.4. SWOT Analysis

            14.2.4.5. Strategic Overview

        14.2.5. American Laboratory Products Company

            14.2.5.1. Company Details

            14.2.5.2. Company Description

            14.2.5.3. Business Overview

            14.2.5.4. SWOT Analysis

            14.2.5.5. Financial Analysis

            14.2.5.6. Strategic Overview

        14.2.6. Sigma Diagnostics Inc.

            14.2.6.1. Company Details

            14.2.6.2. Company Description

            14.2.6.3. Business Overview

            14.2.6.4. SWOT Analysis

            14.2.6.5. Financial Analysis

            14.2.6.6. Strategic Overview

        14.2.7. Sigma Diagnostics Inc.

            14.2.7.1. Company Details

            14.2.7.2. Company Description

            14.2.7.3. Business Overview

            14.2.7.4. SWOT Analysis

            14.2.7.5. Financial Analysis

            14.2.7.6. Strategic Overview

        14.2.8. BioVendor Group

            14.2.8.1. Company Details

            14.2.8.2. Company Description

            14.2.8.3. Business Overview

            14.2.8.4. SWOT Analysis

            14.2.8.5. Financial Analysis

            14.2.8.6. Strategic Overview

List of Tables

Table 01: Global Stool Secretory Immunoglobulin A (SIgA) Market Value (US$ Mn) Forecast, by Use, 2018–2030

Table 02: Global Stool Secretory Immunoglobulin A (SIgA) Market Value (US$ Mn) Forecast, by Use, (Testing) 2018–2030

Table 03: Global Stool Secretory Immunoglobulin A (SIgA) Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 04: Global Stool Secretory Immunoglobulin A (SIgA) Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 05: U.S. Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by Use, 2018–2030

Table 06: U.S. Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by Use (Testing), 2018–2030

Table 07: U.S. Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 08: Canada Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by Use, 2018–2030

Table 09: Canada Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by Use (Testing), 2018–2030

Table 10: Canada Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 11: Europe Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 12: Europe Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by Use, 2018–2030

Table 13: Europe Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by Use (Testing), 2018–2030

Table 14: Europe Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 15: Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 16: Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by Use, 2018–2030

Table 17: Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by Use (Testing), 2018–2030

Table 18: Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 19: Latin America Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 20: Latin America Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by Use, 2018–2030

Table 21: Latin America Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by Use (Testing), 2018–2030

Table 22: Latin America Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 23: Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 24: Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by Use, 2018–2030

Table 25: Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by Use (Testing), 2018–2030

Table 26: Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030

List of Figures

Figure 01: Global Stool Secretory Immunoglobulin A (SIgA) Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Stool Secretory Immunoglobulin A (SIgA) Market Value Share, by Use, 2019

Figure 03: Global Stool Secretory Immunoglobulin A (SIgA) Market Value Share, by End-user, 2019

Figure 04: Global Stool Secretory Immunoglobulin A (SIgA) Market Value Share, by Use (Testing), 2019

Figure 05: Global Stool Secretory Immunoglobulin A (SIgA) Market Value Share, by Region, 2019

Figure 06: Global Stool Secretory Immunoglobulin A (SIgA) Market Value Share Analysis, by Use, 2019 and 2030

Figure 07: Global Stool Secretory Immunoglobulin A (SIgA) Market Revenue (US$ Mn), by Testing, 2018–2030

Figure 08: Global Stool Secretory Immunoglobulin A (SIgA) Market Revenue (US$ Mn), by Research, 2018–2030

Figure 09: Global Stool Secretory Immunoglobulin A (SIgA) Market Value Share Analysis, by Use (Testing), 2019 and 2030

Figure 10: Global Stool Secretory Immunoglobulin A (SIgA) Market Revenue (US$ Mn), by Allergic Disease, 2018–2030

Figure 11: Global Stool Secretory Immunoglobulin A (SIgA) Market Revenue (US$ Mn), by Infection, 2018–2030

Figure 12: Global Stool Secretory Immunoglobulin A (SIgA) Market Revenue (US$ Mn), by GI Inflammation, 2018–2030

Figure 13: Global Stool Secretory Immunoglobulin A (SIgA) Market Revenue (US$ Mn), by Autoimmune Disease, 2018–2030

Figure 14: Global Stool Secretory Immunoglobulin A (SIgA) Market Value (US$ Mn), by Others, 2018–2030

Figure 15: Global Stool Secretory Immunoglobulin A (SIgA) Market Attractiveness Analysis, by Use, 2020–2030

Figure 16: Global Stool Secretory Immunoglobulin A (SIgA) Market Value Share Analysis, by End-user, 2019 and 2030

Figure 17: Global Stool Secretory Immunoglobulin A (SIgA) Market Value (US$ Mn), by Hospitals, 2018–2030

Figure 18: Global Stool Secretory Immunoglobulin A (SIgA) Market Value (US$ Mn), by Labs and Diagnostic Centers, 2018–2030

Figure 19: Global Stool Secretory Immunoglobulin A (SIgA) Market Value (US$ Mn), by Others, 2018–2030

Figure 20: Global Stool Secretory Immunoglobulin A (SIgA) Market Attractiveness Analysis, by End-user, 2020–2030

Figure 21: Global Stool Secretory Immunoglobulin A (SIgA) Market Value Share Analysis, by Region, 2019 and 2030

Figure 22: Global Stool Secretory Immunoglobulin A (SIgA) Market Attractiveness Analysis, by Region, 2020–2030

Figure 23: North America Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 24: U.S. Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 25: U.S. Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by Use, 2019 and 2030

Figure 26: U.S. Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by Use

Figure 27: U.S. Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by Use (Testing), 2019 and 2030

Figure 28: U.S. Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by Use (Testing)

Figure 29: U.S. Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by End-user, 2019 and 2030

Figure 30: U.S. Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by End-user

Figure 31: Canada Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 32: Canada Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by Use, 2019 and 2030

Figure 33: Canada Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by Use

Figure 34: Canada Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by Use (Testing), 2019 and 2030

Figure 35: Canada Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by Use (Testing)

Figure 36: Canada Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by End-user, 2019 and 2030

Figure 37: Canada Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by End-user

Figure 38: Europe Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 39: Europe Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 40: Europe Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 41: Europe Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by Use, 2019 and 2030

Figure 42: Europe Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by Use

Figure 43: Europe Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by Use (Testing), 2019 and 2030

Figure 44: Europe Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by Use (Testing)

Figure 45: Europe Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by End-user, 2019 and 2030

Figure 46: Europe Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by End-user

Figure 47: Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 48: Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 49: Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness, by Country/Sub-region

Figure 50: Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by Use, 2019 and 2030

Figure 51: Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by Use

Figure 52: Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by Use (Testing), 2019 and 2030

Figure 53: Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by Use (Testing)

Figure 54: Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by End-user, 2019 and 2030

Figure 55: Asia Pacific Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by End-user

Figure 56: Latin America Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 57: Latin America Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 58: Latin America Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness, by Country/Sub-region

Figure 59: Latin America Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by Use, 2019 and 2030

Figure 60: Latin America Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by Use

Figure 61: Latin America Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by Use (Testing), 2019 and 2030

Figure 62: Latin America Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by Use (Testing)

Figure 63: Latin America Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by End-user, 2019 and 2030

Figure 64: Latin America Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by End-user

Figure 65: Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 66: Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 67: Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness, by Country/Sub-region

Figure 68: Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by Use, 2019 and 2030

Figure 69: Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by Use

Figure 70: Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by Use (Testing), 2019 and 2030

Figure 71: Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by Use (Testing)

Figure 72: Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Value Share Analysis, by End-user, 2019 and 2030

Figure 73: Middle East & Africa Stool Secretory Immunoglobulin A (SIgA) Diagnostic Market Attractiveness Analysis, by End-user

Figure 74: Tecan Trading AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019

Figure 75: Tecan Trading AG Breakdown of Net Sales (%), by Region/Country, 2019

Figure 76: Tecan Trading AG Breakdown of Net Sales (%), by Business Segment, 2019

Figure 77: Tecan Trading AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2019

Copyright © Transparency Market Research, Inc. All Rights reserved

Stool Secretory Immunoglobulin A [SIgA] Market

Schedule a Call